HOW TO DEAL WITH ‘LONG COVID’ IN KIDS - The Daily Guardian
Connect with us

Medically Speaking

HOW TO DEAL WITH ‘LONG COVID’ IN KIDS

Published

on

Coronavirus has left a scar on our minds, and its impact is not only felt by adults but kids as well. The concept of ‘long COVID’ is not well defined yet, but there are several research papers that highlight the long-term effects of COVID on various age groups. Children who have battled COVID are coming back to hospitals with post-COVID symptoms like persistent headaches, fatigue, abdominal pain, gastric issues, heart palpitations, difficulty to sleep, muscle pain, loss of smell, and Tachycardia (increased heart rate). This symptom typically manifests after 2-4 weeks of the initial infection and may last for weeks to months. 

RISK FACTORS FOR KIDS: Adolescents and teenagers may be prone to witness long COVID symptoms. Moreover, children with higher BMI or obesity are at higher risk of experiencing long COVID.  Initially, we were under the impression that long COVID can occur in kids having acute infections. However, that has changed over time, and we see a lot of children with asymptomatic and mild infection also experiencing long COVID. Having said that it is important to note that kids experiencing such symptoms should be properly screened by medical experts as many of these could be a result of mental health issues induced by the lockdown and pandemic. 

 There are studies that indicate that isolation and lockdown have resulted in mental health issues among kids, further resulting in headaches, fatigue, anger, misbehaviour, and similar issues. Parents and doctors need to ensure proper diagnosis of these health ailments. 

MULTISYSTEM INFLAMMATORY SYNDROME (MIS-C) A CAUSE OF MANY SUCH LONG COVID ISSUES IN KIDS: MIS-C in children is a condition where different body parts can become inflamed, including the heart, lungs, kidneys, brain, skin, eyes, or gastrointestinal organs. We know that many children with MIS-C had the COVID virus or had been around someone with COVID19. When a child’s immune system reacts extensively to fight the virus in such cases, the immune system adopts in abnormal ways to fight the disease and that’s when organs start to get inflamed causing MIS-C. MIS-C can be serious, even deadly, but most children diagnosed with this condition have gotten better with medical care. 

SYMPTOMS OF MIS-C: Signs and symptoms of MIS-C in children include: 

• High-grade fever that lasts 24 hours or longer 

• Vomiting 

• Diarrhoea 

• Pain in the stomach 

• Skin rash 

• Feeling unusually tired 

• Fast heartbeat 

• Rapid breathing 

• Red eyes 

• Redness or swelling of the lips and tongue 

• Redness or swelling of the hands or feet 

• Headache, dizziness, or light-headedness 

DIAGNOSIS AND TREATMENT OF MIS-C: If MIS-C is suspected, a diagnostic or antibody test for COVID19 can help confirm current or past infection with the virus, which aids in diagnosis and treatment. 

TESTS YOUR DOCTOR MAY PRESCRIBE, TO LOOK FOR INFLAMMATION OR OTHER SIGNS OF THE DISEASE, INCLUDE: 

• CBC Blood tests 

• C-reactive protein test 

• Chest X-ray 

• Heart ultrasound (echocardiogram) 

• Abdominal ultrasound 

Usually, supportive care for symptoms i.e., medicine and/or fluids are given to make your child feel better, coupled with various medicines to treat inflammation. Most children who become ill with MIS-C will need to be treated in the hospital. To treat this condition normally, Intravenous Immunoglobulin (IVIG) to improve antibody content or steroids in appropriate dosages is given. All these medications are given, and the children are kept under observation. Some children may need to be treated in the Paediatric Intensive Care Unit (ICU) if they are severely ill. 

Above all, prevention is always better than cure. Vaccinate your kids with the flu vaccine to reduce the impact of any viral infection. More so, follow COVID-appropriate norms at home and outside. Ensure that your kids stay hygienic and maintain COVID19 norms. 

The Author is Consultant Paediatrics & Neonatology, Fortis Hiranandani Hospital Vashi & Dr Asmita Mahajan, Consultant Neonatology & Paediatrics, SL Raheja Hospital, Mahim. 

The Daily Guardian is now on Telegram. Click here to join our channel (@thedailyguardian) and stay updated with the latest headlines.

For the latest news Download The Daily Guardian App.

Medically Speaking

WHAT IS THE RIGHT TIME FOR BOOSTER DOSE OF COVID VACCINE?

Opening the third or booster dose for the healthcare and frontline workers as well as senior citizens with comorbidities will help the country protect its high-risk population, given the rising concerns of a third wave due to a variant of concern, Omicron.

Published

on

India has achieved the landmark of administering over 140 crores COVID-19 vaccination to its population, which has been globally acclaimed as a phenomenal achievement. India’s vaccination programme had started on 16 January 2021, and all vulnerable groups of the population received both doses in the first half of 2021. As a result of this, a significant majority of the population have developed antibodies, combined with those who have recovered from naturally acquired infection.

However, there is uncertainty regarding the duration of protection being offered as a result of the probable waning away of antibodies. Also, there have been instances of individuals being diagnosed with COVID despite having had two doses of COVID-19 vaccination. It is promising to note that the Indian government has considered the recommendation of the scientific committee of AHPI to introduce booster dose, to at least the vulnerable group, to begin with. The recommendation was made by the AHPI scientific committee, which deliberated on the subject in November 2021. The government is considering enabling the booster dose to be given to eligible people voluntarily. Ample stock of COVID-19 vaccine is available with the private sector also, and these may be effectively utilised for this purpose.

Prime Minister Narendra Modi recently announced the launch of the vaccination campaign for children in the age group of 15-18 years who form a major part of the unvaccinated, susceptible population in India. Moreover, opening the third or Booster dose for the healthcare and frontline workers as well as the senior citizens with comorbidities will help the country to protect its high-risk population, given the rising concerns of a third wave due to a variant of concern- Omicron.

The third or booster dose will help India to fight against the COVID-19 pandemic and will aid in checking the severity of Omicron. Unfortunately, the second wave had resulted in unprecedented death and destruction in its wake all over the country. It is time to take urgent action to enable the nation to be in a better position to face or avoid future waves. Apart from social distancing and masking, universal vaccination is a viable answer to prevent future waves. While the majority of the people in metro areas have relatively easy access to immunisation, a more focused effort for rural areas of the country is also urgently needed.

AHPI has been at the forefront, supporting the government at every stage during the pandemic. The private sector provides over 70% of healthcare, and in both the first and second waves, private healthcare has been a strong supporter, treating the majority of patients across the country. The private sector has also been partnering with the Government to ensure that as many possible adults are vaccinated before any future waves.

The scientific committee of AHPI has also suggested that the gap between the second dose and this third dose should be between 6 to 12 months.

With the emergence of new variants, the need for a third dose that may operate as a booster to the body’s immune system was felt all across the world, and numerous countries began delivering this third dose, also known as a booster dose.

Finally, studies have shown that immunity is protecting people against the effects of COVID-19. Hence, the priority should be universal vaccination. The virus thrives due to a lack of adequate vaccine coverage. When a virus infects and reproduces in tens of thousands of people, it has the potential to mutate, leading to the emergence of new variants. To prevent more VOCs from appearing, India needs to get ahead of the virus. If India achieves Universal Vaccination, it can hope to lessen the impact of the pandemic. The booster dose is one step forward towards safeguarding vulnerable and other groups.

The writer is President, Association of Healthcare Providers-India (AHPI).

Continue Reading

Medically Speaking

SOCIALLY ISOLATED OLDER ADULTS MAY HAVE FEWER TEETH: STUDY

Published

on

Researchers have found that older people who are socially isolated tend to lose their teeth more quickly than those with more social interaction.

The study involved observing older Chinese adults and was led by researchers at NYU Rory Meyers College of Nursing. The findings were published in ‘Community Dentistry and Oral Epidemiology.

“Our study suggests that maintaining and improving social connections may benefit the oral health of older adults,” said Xiang Qi, a PhD student at NYU Meyers and the study’s first author. “The findings align with previous studies demonstrating that structural indicators of social disconnection can have powerful effects on indicators of health and well-being,” he said.

Social isolation and loneliness in older adults have been major public health concerns around the world and are risk factors for heart disease, mental health disorders, cognitive decline, and premature death. In some countries, including the United States and China, up to one in three older adults were lonely, according to the World Health Organization. The COVID-19 pandemic had exacerbated these issues among older adults, as many in-person interactions had been interrupted to protect older adults from infection.

Social isolation and loneliness are related but different. Social isolation has been defined as having few social relationships or infrequent social contact with others, while loneliness referred to the feeling created by a lack of social connection.

“While social isolation and loneliness often go hand in hand, it’s possible to live alone and be socially isolated but to not feel lonely, or to be surrounded by people but still feel lonely,” said Bei Wu, Dean’s Professor in Global Health at NYU Meyers and the study’s senior author.

Older adults are also at risk for another health concern: losing teeth. In China, older adults aged 65 to 74 had fewer than 23 teeth on average (adults typically have 32 teeth, or 28 if wisdom teeth have been removed) and 4.5 per cent of this age group had lost all of their teeth.

Gum disease, smoking, lack of access to dental care, and chronic illnesses like diabetes and heart disease increase the risks of tooth loss. Missing teeth could have a significant impact on one’s quality of life, affecting nutrition, speech, and self-esteem.

To understand the relationship between social isolation, loneliness, and tooth loss in older adults in China, the researchers used the Chinese Longitudinal Healthy Longevity Survey to analyse data from 4,268 adults aged 65 and up. The participants completed surveys at three different time points (2011-12, 2014, and 2018), which captured measures of social isolation and loneliness, how many teeth people had and lost over the 7-year study, and other factors. More than a quarter (27.5 per cent) of the study participants were socially isolated, and 26.5 per cent reported feeling lonely.

The researchers found that higher levels of social isolation were associated with having fewer teeth and losing teeth more quickly over time, even when controlling for other factors such as oral hygiene, health status, smoking and drinking, and loneliness. Older adults who were socially isolated had, on average, 2.1 fewer natural teeth and 1.4 times the rate of losing their teeth than those with stronger social ties.

“Socially isolated older adults tend to be less engaged in social and health-promoting behaviours like physical activity, which could have a negative impact on their overall functioning and oral hygiene, as well as increase their risk for systemic inflammation,” said Wu. “This functional impairment seems to be a major pathway linking social isolation to tooth loss.”

Surprisingly, loneliness was not associated with the number of remaining teeth, nor with the rate of tooth loss.

“While social isolation can result in a lack of support that can affect health behaviours, for older adults who feel lonely, it’s possible that their social networks are still in place and can help them to keep up healthy behaviours,” said Qi.

The findings highlighted the importance of developing interventions to reduce social isolation.

Continue Reading

Medically Speaking

Breakthrough COVID-19 infections spur strong antibody responses: Study

Published

on

In view of the spike in COVID-19 infections globally, a recent study shed light on the strength, durability, and breadth of neutralising antibody responses generated by breakthrough infections in individuals vaccinated against SARS-CoV-2.

Alexandra Walls and David Veesler in the Department of Biochemistry at the University of Washington in Seattle led the project.

Characteristics of the Delta and Omicron coronavirus variants of concern included enhanced transmissibility and immune evasion even in non-immunologically naive individuals, compared to the ancestral pandemic coronavirus.

These characteristics, and the waning of immunity from vaccines, have led to breakthrough infections in vaccinated individuals. For the most part, otherwise healthy people who were vaccinated against the SARS-CoV-2 usually did not have severe symptoms if they did end up contracting the virus.

The researchers wanted to understand what effect catching the virus after being vaccinated had on neutralizing antibodies, and to see how durable and broad these responses were. Their hope was that advancing such knowledge would help guide vaccination policies and pandemic mitigation strategies.

Through their project the researchers learned that the degree of antibody response depended on whether a person has had one, two, three, or four exposures to the spike protein through infection, vaccination, or a mixture of the two. The scientists also checked antibody responses in groups of individuals who had been vaccinated after having COVID-19, those who were previously vaccinated and experienced a breakthrough infection, those who were vaccinated only, and those who were boosted and therefore vaccinated three times.

Among their study subjects, those who had completed a three-vaccination protocol, and those who had been vaccinated after recovering from COVID-19, and those with a breakthrough infection after vaccination launched almost comparable neutralizing antibody responses, in terms of magnitude and breadth. Their serum binding and antibody neutralizing responses to the spike protein in the current pandemic coronavirus variants were much more potent and lasting than those generated by people who had received only two doses of COVID-19 vaccine or who had a previous infection not followed by vaccination.

This observation suggested that the increased number of exposures to SARS-CoV-2 antigens, either through infection and vaccination or triple vaccination, enhanced the quality of antibody responses.

The researchers also looked at how broad the elicited antibodies could be. They investigated neutralization of the divergent Omicron SARS-CoV-2 variant of concern, currently responsible for the majority of cases in the United States. Their findings showed that boosted individuals (or those that have a mixture of infection and double vaccination) have neutralizing antibodies at similar levels to subjects vaccinated twice against the original ancestral strain. This suggested a large amount of immune evasion, but that vaccine boosters could help close the neutralizing antibody gap caused by Omicron.

Looking outside of the SARS-CoV-2 family showed a similar pattern, where repeated and multiple exposures improved the otherwise weak neutralizing antibody response to SARS-CoV. Finally, the authors did not identify improvements in antibody binding to common cold causing coronavirus spike proteins like OC43 or HKU1.

This suggested that repeated SARS-CoV-2 exposure does not improve spike reactivity to more divergent coronaviruses. These findings supported the development of broader sarbecovirus or coronavirus vaccines to be prepared in the event of a future spillover event.

The study groups consisted of about 15 people, from the Hospitalized or Ambulatory Adults with Respiratory Viral Infections, or HAARVI, project at the UW in Seattle. HAARVI, led by UW Medicine infectious disease physician Helen Chu, looked at recovered COVID-19 patients to study immune responses over time, to understand the long-term consequences of the infection, and to compare immune responses from vaccines and natural infections.

The findings were published in ‘Cell’, one of the scientific journals of Cell Press.

Continue Reading

Medically Speaking

FERTILITY TREATMENT DURING PANDEMIC

Published

on

The COVID-19 pandemic caused fertility clinic closures worldwide. These closures were abrupt and sudden, patients undergoing treatment lost access to services during the first phase of the pandemic, the cycles that were in progress were abandoned which led to the freezing of all embryos in an IVF cycle without a fresh embryo transfer.

The COVID-19 pandemic has claimed the lives of over one million people worldwide and has affected all aspects of healthcare worldwide including the delivery of care to patients with fertility-related diagnoses.

Subsequently, only emergency medical services were functioning and all the assisted reproductive technology (ART) clinics were shut down which had an enormous impact on the patients already undergoing infertility treatment economically as well as mentally. But, as the ongoing coronavirus pandemic situation is stabilising, it becomes essential to resume the ART services in a gradual manner. However, strict vigilance and a stepwise approach to the treatment are being adhered to, to minimise the risks related to COVID-19 infection to patients and healthcare staff.

• Patients are fully informed about the nature of the Covid-19 pandemic and its effect on their treatment and future pregnancy outcome(s).

• Patients acknowledge all the facts and give informed consent for the fertility treatment at this particular time.

• The ART clinics modified their layout and working practices in accordance with National and local guidelines for Covid-19.

Couples are strongly advised to take an RT-PCR test before commencing treatment. This must be repeated before any ART procedure that is considered invasive and requires regional or general anaesthesia such as egg retrieval, HCG trigger or embryo transfer. It is advised that the test is done less than three days prior to the procedure. To avoid getting infected, patients are strongly recommended, partners and potential donors are advised to self-isolate from the beginning of ovarian stimulation until the procedure is finished.

When the pandemic first hit, there was a fear about the safety to conceive or even visiting the clinic for consultations. But people are more informed now.

In recent weeks, the highly contagious Omicron variant of COVID-19 has resulted in a surge of new cases across India and other countries. Mostly, all ART Clinics have additional protective measures in place, Staff members who cannot maintain a 2m distance from patients are required to wear an isolation gown, N95 mask, eye protection, and gloves to minimise transmission. Clinics are conducting regular Rapid Antigen tests on all their clinic staff members.

In addition to the existing precautions and safety measures a vaccine policy for all of our team members is being implemented, all staff must complete COVID-19 screening forms daily before entering the clinic.

The additional protocols followed by the clinics will ensure safety and will continue to offer all fertility services while maintaining a safe clinic environment for patients and staff.

For patients currently undergoing treatment, Self-monitoring for COVID-19 symptoms and completing pre-screening forms before appointments is mandatory. Patients are advised not to visit the clinic if experiencing any symptoms or are feeling unwell.

Patients are advised of getting fully vaccinated now to decrease the risk of developing a severe COVID-19 infection and to further reduce the risk of transmission. Recent public health initiatives have expanded vaccine eligibility, and all of our patients (whether they are trying to get pregnant or are already pregnant) are advised and encouraged to book appointments to receive their 1st, 2nd or booster dose when available.

In compliance with public health guidelines, ART Clinics continue to carefully minimise the number of people inside the clinics at any given time. To mitigate the risks of exposure for everyone, a no visitor policy is enforced.

All patients are encouraged to maintain social distancing, practice good hand hygiene and be diligent about social gatherings. All patients are required to wear a medical face mask at all times during their visit to the clinic. Nonetheless, this is a particularly challenging time for patients with infertility. Under the best of circumstances, infertility treatment is a time of uncertainty and emotional challenges; the coronavirus pandemic has intensified the distress many couples experience in this setting, while at the same time cutting off access to important sources of support, including family, friends, support groups, and professional mental health services.

Dr Rita Bakshi is the founder of RISAA IVF.

Continue Reading

Medically Speaking

MORE THAN 5 HOURS’ EMERGENCY WAIT BEFORE ADMISSION LINKED TO INCREASED DEATH RISK: STUDY

Published

on

A new study has found that waiting for more than five hours in emergency care before admission to the hospital is associated with a heightened risk of death from any cause within the next 30 days.

This can be measured and represented as a ‘number needed to harm metric’, of 1 extra death for every 82 patients delayed after 6-8 hours, concluded the researchers.

The 4-hour waiting time target before hospital discharge, admission, or transfer was introduced in 2004 in England, and shortly afterward in the other devolved nations of the UK, in a bid to tackle emergency department overcrowding.

Several other countries, including Canada and Australia, followed suit with similar measures. But in recent years, performance against this target has steadily declined amid rising patient demand.

Delays to timely admission from emergency departments have been linked to patient harm, and the researchers wanted to quantify the increased risk of death resulting from these delays.

They drew on Hospital Episode Statistics and Office of National Statistics data for England, covering every patient admitted to hospital from each major (type 1) emergency department in England between April 2016 and March 2018.

They compared recorded deaths from any cause within 30 days of admission with those that would be expected, allowing for a wide range of potentially influential factors.

These included sex, age, deprivation level, concurrent conditions, time of the day and month, previous attendances/emergency admissions, and crowding in the emergency department at the time.

Between April 2016 and March 2018, 26,738,514 people attended an emergency department in England: 5,249,891 of them were admitted to the hospital.

In all, 433,962 people died within 30 days during the study period. The overall unadjusted 30-day death rate was just under 9 per cent.

The average age of patients admitted was 55; the number of concurrent conditions rose in tandem with increasing age. Nearly twice as many patients came from areas of greatest deprivation as came from areas of least deprivation.

The most frequent time of arrival was between 12:00 and 17:59 hours, with the first 3 months of the year accounting for the biggest proportion of patients. The average wait in the emergency department was just under 5 hours; the breach rate of the 4-hour waiting time target averaged around 38 per cent

A statistically significant linear increase in the death rate emerged for waits longer than 5 hours in the emergency department.

After accounting for potentially influential risk factors, the death rate was 8 per cent higher than expected among those patients waiting between 6-8 hours before admission to hospital, and 10 per cent higher than expected for those waiting 8-12 hours, compared with patients moving on within 6 hours.

This can be measured and represented as a ‘number needed to harm metric’, of 1 extra death for every 82 patients delayed for 6-8 hours, said the researchers.

“The results from this study show that there is a ‘dose-dependent’ association between time in excess of 5 hours in the [emergency department] for admitted patients and their all-cause 30-day mortality,” they wrote.

“Moreover, 30-day mortality is a relatively crude metric that does not account for either increase in patient morbidity or for the inevitably worse patient experiences,” they added.

This is an observational study, and as such, can’t establish cause and effect.

But, said the researchers, “Despite limited supporting evidence, there are a number of clinically plausible reasons to accept that there is a temporal association between delayed admission to a hospital inpatient bed and poorer patient outcomes.”

Long stays in the emergency department are associated with exit block and crowding, which can delay access to vital treatments. And they are associated with an increase in subsequent hospital length of stay, especially for older patients, noted the researchers.

This, in turn, increases the risk of hospital-acquired infection and physiological and psychological deconditioning, they said.

Exit block is usually also related to bed occupancy levels, which are highest in the late afternoon and usually lower around midnight. A disproportionate number of delayed patients are therefore likely to be moved to a ward during the night when staffing levels are lowest, they added.

And they concluded, “This study confirms that healthcare policymakers should continue to mandate timely admission from the [emergency department] in order to protect patients from hospital-associated harm.”

In a linked editorial, Derek Prentice, lay member for the Royal College of Emergency Medicine, insisted, “Let nobody be in doubt any longer, the NHS 4-hour operational target is, as many of us have always known, of key importance to patient safety.”

With sufficient funding for NHS beds and staff and social care provision, and prioritisation from NHS leaders, hospitals should be able to meet this target, he said. But these have been in short supply in recent years, he suggested. “Could there be better measures? Possibly, but until there are, and crucially, ones that have the support and trust of patients, the 4-hour target or one very close to this, must remain the gold standard. Those in doubt need look no further than the evidence provided by this excellent paper,” he asserted.

The Study has been published in the Emergency Medicine Journal ‘.

Continue Reading

Medically Speaking

STUDY FINDS COVID-19 VACCINES OFFER LASTING PROTECTION

Published

on

A new research has found that COVID-19 vaccination offers long-lasting protection from the worst outcomes of COVID-19.

The emergence of the delta and omicron variants had raised questions about whether breakthrough infections are caused by waning immunity or by the more transmissible variants.

Results of the study suggested that declining immunity is responsible for breakthrough infections, but vaccines maintained protection from hospitalization and severe disease nine months after getting the first shot.

“The primary takeaway message from our study is that unvaccinated people should get vaccinated right away,” said lead study author Danyu Lin, PhD, Dennis Gillings Distinguished Professor of Biostatistics at the UNC Gillings School of Global Public Health.

“The results of our study also underscore the importance of booster shots, especially for older adults,” Lin added.

The study, which is a collaboration between the UNC-Chapel Hill and the North Carolina Department of Health and Human Services, examined data on COVID-19 vaccination history and health outcomes for 10.6 million North Carolina residents between December 2020 and September 2021.

The study results were used by the Centres for Disease Control and Prevention to support the use of booster shots.

“This is an excellent example of the wonderful research partnership between the Gillings School and NCDHHS, who are working together to generate the evidence base needed to keep our communities safe,” said Penny Gordon-Larsen, PhD, Carla Smith Chamblee Distinguished Professor of Global Nutrition and associate dean for research at UNC Gillings School of Global Public Health

This data included outcomes from COVID-19 cases caused by the delta variant. However, data from this study were collected before the discovery of the omicron variant.

“By applying a novel methodology to the rich surveillance data, we were able to provide a precise and comprehensive characterization of the effectiveness over a nine-month period for the three vaccines employed in the U.S.,” Lin said.

“Unlike previous studies, we estimated the vaccine effectiveness in reducing the current risks of COVID-19, hospitalization, and death as a function of time elapsed since the first dose,” Lin continued.

“This information is critically important in determining the need for and the optimal timing of booster vaccination,” Lin added.

The study found that the effectiveness of the Pfizer and Moderna mRNA vaccines in reducing the risk of COVID-19 reached a peak of about 95 per cent two months after the first dose and then gradually declined. At seven months, the Pfizer vaccine dropped to 67 per cent effectiveness, compared to the Moderna vaccine, which maintained 80 per cent effectiveness.

Among early recipients of the two mRNA vaccines, effectiveness dropped dramatically from mid-June to mid-July, when the delta variant was surging.

Effectiveness for the Johnson & Johnson adenovirus vaccine was 75 per cent at one month after injection and fell to 60 per cent after five months. All three vaccines were effective at keeping people out of the hospital due to severe COVID-19. Effectiveness of the Pfizer vaccine reached a peak of 96 per cent at two months and remained around 90 per cent at seven months; effectiveness of the Moderna vaccine reached a peak of 97 per cent at two months and remained at 94 per cent at seven months. The effectiveness of the Johnson & Johnson vaccine reached a peak of 86 per cent at two months and was higher than 80 per cent through six months.

For all three vaccines, effectiveness against death was higher than that of hospitalization.

“Because the majority of the vaccines in the U.S. were administered more than seven months ago and only a small percentage of the population has received boosters, waning immunity is likely contributing to the breakthrough infections with the omicron variant,” Lin said.

Everyone age 5 and older are eligible for a COVID-19 vaccine. Those ages 18 and up should get a booster shot.

The research was led by Lin with major contributions from Yu Gu, a doctoral student in biostatistics, and Donglin Zeng, PhD, professor of biostatistics. NCDHHS epidemiologists Bradford Wheeler, Hayley Young, Shadia Khan Sunny, and Zack Moore participated in the research. Shannon Holloway from the North Carolina State Department of Statistics also contributed.

The research has been published in the ‘New England Journal of Medicine ‘

Continue Reading

Trending